JAMA: 2011-02-02, Vol. 305, No. 5, Author in the Room ™ Audio Interview
Interview with Gabriela Schmajuk, MD, author of Receipt of Disease-Modifying Antirheumatic Drugs Among Patients With Rheumatoid Arthritis in Medicare Managed Care Plans. Summary Points: 1. One third of Medicare managed care patients diagnosed with rheumatoid arthritis are not receiving disease-modifying antirheumatic drugs. 2. There is variation in disease-modifying antirheumatic drug receipt based on "accidental factors": sociodemographics, geographic location, and health plan. 3. Because disease-modifying antirheumatic drug use is the main way to affect outcomes in rheumatoid arthritis, these patient groups and the physi...
Source: JAMA Author in the Room - March 18, 2011 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts
JAMA: 2011-02-02, Vol. 305, No. 5, Author in the Room™ Audio Interview
Interview with Gabriela Schmajuk, MD, author of Receipt of Disease-Modifying Antirheumatic Drugs Among Patients With Rheumatoid Arthritis in Medicare Managed Care Plans. Summary Points: 1. One third of Medicare managed care patients diagnosed with rheumatoid arthritis are not receiving disease-modifying antirheumatic drugs. 2. There is variation in disease-modifying antirheumatic drug receipt based on "accidental factors": sociodemographics, geographic location, and health plan. 3. Because disease-modifying antirheumatic drug use is the main way to affect outcomes in rheumatoid arthritis, these patient groups and the physi...
Source: JAMA Author in the Room - March 18, 2011 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts
Rheumatoid Arthritis
In this podcast Dr Jean Lee looks at rheumatoid arthritis (Source: Podmedics - Medical Podcasts)
Source: Podmedics - Medical Podcasts - March 4, 2011 Category: Journals (General) Authors: Podmedics Source Type: podcasts
New Arthritis Therapies: Beyond Anti-inflammatory Meds
Dr. Charles Argoff discusses new and emerging musculoskeletal pain therapies resulting from a more profound etiologic understanding of conditions such as osteoarthritis and lower back pain. (Source: Medscape Orthopaedics Podcast)
Source: Medscape Orthopaedics Podcast - December 8, 2010 Category: Orthopaedics Authors: Medscape Source Type: podcasts
Rheumatoid Arthritis
Dr Ngian discusses rheumatoid arthritis, a chronic disease which is known to cause significant irreversible joint damage and disability if the so-called 'window of opportunity' for treatment is missed. Dr Ngian discusses the aetiology and typical clinical features of rheumatoid arthritis, and the investigations required if this type of arthritis is suspected, to ensure early recognition and referral. She uses the RACGP recently-published Guidelines for the diagnosis and management of early rhuematoid arthritis to discuss treatment options, and how to monitor patients on disease-modifying anti-rheumatic drugs and biologic a...
Source: Australian Family Physician audio - August 31, 2010 Category: Primary Care Authors: The Royal Australian College Of General Practitioners Tags: Podcasts Source Type: podcasts
Aches and Pains and Osteoarthritis
GP Dr Louise Stone discusses assessment and management of osteoarthritis in General Practice with Dr Kathryn O'Connor. Patient history is important; especially duration and severity of pain. Alternative diagnoses should be considered and excluded. Education and patient self management are vital as the management of osteoarthritis happens mainly outside the consulting room. Treatment modalities include exercise, weight loss, topical and oral medications, appliances. Referral to a surgeon may be required to allow the patient to gather information about future treatment options. Oraganisations such as Arthritis Australia can ...
Source: Australian Family Physician audio - October 31, 2008 Category: Primary Care Authors: The Royal Australian College Of General Practitioners Tags: Podcasts Source Type: podcasts
The Lancet: March 25, 2008
Josef Smolen from the Medical University of Vienna, Austria, discusses in this week's podcast how the monoclonal antibody tocilizumab could be effective in treating rheumatoid arthritis. Tocilizumab blocks interleukin 6, a pro-inflammatory cytokine involved in the biological process behind rheumatoid arthritis (Source: Listen to The Lancet)
Source: Listen to The Lancet - March 25, 2008 Category: General Medicine Authors: The Lancet Source Type: podcasts
Fibromyalgia Is Not a Rheumatologic Disease Anymore
George T. Griffing, MD, Professor of Medicine, Saint Louis University, Saint Louis, Missouri; Editor-in-Chief, Internal Medicine, eMedicine, discusses whether we should believe in fibromyalgia. (Source: MedGenMed Weekly Editorials from Medscape.com)
Source: MedGenMed Weekly Editorials from Medscape.com - February 25, 2008 Category: Journals (General) Authors: George T. Griffing, MD Source Type: podcasts
ASFH Uveitis Associated with Juvenile Idiopathic Arthritis
Guest: Jennifer E. Thorne, M.D.Associate Professor of Ophthalmology Division of Ocular ImmunologyThe Wilmer Eye InstituteBaltimore, MD (Source: As Seen From Here)
Source: As Seen From Here - April 15, 2007 Category: Opthalmology Authors: JYoungMD at gmail.com Source Type: podcasts
Work related upper limb disorders
are common, expensive and difficult to treat. Rheumatologist and occupational physician Dr Michael Shanahan talks to Steve Trumble about effective management approaches, and answers the question: "where has all the RSI gone?". (Source: Australian Family Physician audio)
Source: Australian Family Physician audio - November 30, 2006 Category: Primary Care Authors: The Royal Australian College Of General Practitioners Tags: Podcasts Source Type: podcasts
